BICO Shareholders Approve New Board Line-Up and Long-Term Incentive Plan at AGM

BICO Group AB Class B ( (SE:BICO) ) just unveiled an announcement.

BICO Group AB held its Annual General Meeting in Gothenburg, where shareholders approved the 2025 accounts, discharged the board and CEOs from liability, and decided that no dividend will be paid, with profits carried forward to support the company’s financial position. The AGM also confirmed Deloitte AB as auditor, approved the 2025 remuneration report, and set new board and committee fees.

The meeting re-elected four directors, appointed Erik Gatenholm and Olof Stranding as new board members, and confirmed Maria Rankka as chair, signaling continuity alongside refreshed governance. Shareholders further approved a new 2026–2029 long-term share-based incentive plan for 25 key employees, tied mainly to total shareholder return and adjusted EBITDA margin, which could dilute share capital by up to about 1.02% and is intended to align management incentives with shareholder value creation.

More about BICO Group AB Class B

BICO Group AB is a life-science technology company that leverages a global portfolio of brands combining automation, intelligence and data to accelerate scientific discovery in pharma and biotech. Its installed base exceeds 53,600 instruments in more than 65 countries, serving over 3,500 laboratories including the world’s top 20 pharmaceutical companies, and it is listed on Nasdaq Stockholm’s Mid Cap market.

Average Trading Volume: 284,065

Technical Sentiment Signal: Sell

Current Market Cap: SEK1.37B

See more insights into BICO stock on TipRanks’ Stock Analysis page.